Criteria for diagnosis, staging, risk stratification and response assessment of multiple myeloma

被引：835

作者：

Kyle, R. A. ^{[1
]}

Rajkumar, S. V. ^{[1
]}

机构：

[1] Mayo Clin, Div Hematol, Dept Internal Med, Rochester, MN 55905 USA

来源：

LEUKEMIA | 2009年 / 23卷 / 01期

关键词：

diagnosis; myeloma; prognosis; response; staging; treatment; LIGHT-CHAIN RATIO; IGM MONOCLONAL GAMMOPATHY; TERM-FOLLOW-UP; UNDETERMINED SIGNIFICANCE; SOLITARY PLASMACYTOMA; WALDENSTROMS MACROGLOBULINEMIA; POOR-PROGNOSIS; SYSTEM; SURVIVAL; CHROMOSOME-13;

D O I：

10.1038/leu.2008.291

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

New systems have emerged for diagnosis, staging and response assessment in multiple myeloma (MM). The diagnostic and response criteria recommended are primarily derived from the International Myeloma Working Group, with certain updates and clarifications. The International Staging System is the current standard for staging of myeloma. A new risk stratification model is provided to specifically define high-risk patients who may benefit from novel therapeutic strategies. This paper provides the current criteria for diagnosis, staging, risk stratification and response assessment of MM.

引用

页码：3 / 9

页数：7

共 30 条

[1] Clinically relevant end points and new drug approvals for myeloma [J].

Anderson, K. C. ;

Kyle, R. A. ;

Rajkumar, S. V. ;

Stewart, A. K. ;

Weber, D. ;

Richardson, P. .

LEUKEMIA, 2008, 22 (02) :231-239

[2] Immunoglobulin M monoclonal gammopathies of undetermined significance and indolent Waldenstrom's macroglobulinemia recognize the same determinants of evolution into symptomatic lymphoid disorders: Proposal for a common prognostic scoring system [J].

Baldini, L ;

Goldaniga, M ;

Guffanti, A ;

Broglia, C ;

Cortelazzo, S ;

Rossi, A ;

Morra, E ;

Colombi, M ;

Callea, V ;

Pogliani, E ;

Ilariucci, F ;

Luminari, S ;

Morel, P ;

Merlini, G ;

Gobbi, P .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (21) :4662-4668

[3] SERUM BETA-2-MICROGLOBULIN AND SURVIVAL DURATION IN MULTIPLE-MYELOMA - A SIMPLE RELIABLE MARKER FOR STAGING [J].

BATAILLE, R ;

DURIE, BGM ;

GRENIER, J .

BRITISH JOURNAL OF HAEMATOLOGY, 1983, 55 (03) :439-447

[4]

Blade Joan, 1998, British Journal of Haematology, V102, P1115, DOI 10.1046/j.1365-2141.1998.00930.x

[5]

Dimopoulos MA, 2000, BLOOD, V96, P2037

[6] Solitary plasmacytoma of bone and extramedullary plasmacytoma [J].

Dimopoulos, MA ;

Kiamouris, C ;

Moulopoulos, LA .

HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 1999, 13 (06) :1249-+

[7] Immunoglobulin free light chains and solitary plasmacytoma of bone [J].

Dingli, David ;

Kyle, Robert A. ;

Rajkumar, S. Vincent ;

Nowakowski, Grzegorz S. ;

Larson, Dirk R. ;

Bida, John P. ;

Gertz, Morie A. ;

Therneau, Terry M. ;

Melton, L. Joseph, III ;

Dispenzieri, Angela ;

Katzmann, Jerry A. .

BLOOD, 2006, 108 (06) :1979-1983

[8] POEMS syndrome: definitions and long-term outcome [J].

Dispenzieri, A ;

Kyle, RA ;

Lacy, MQ ;

Rajkumar, SV ;

Therneau, TM ;

Larson, DR ;

Greipp, PR ;

Witzig, TE ;

Basu, R ;

Suarez, GA ;

Fonseca, R ;

Lust, JA ;

Gertz, MA .

BLOOD, 2003, 101 (07) :2496-2506

[9] Immunoglobulin free light chain ratio is an independent risk factor for progression of smoldering (asymptomatic) multiple myeloma [J].

Dispenzieri, Angela ;

Kyle, Robert A. ;

Katzmann, Jerry A. ;

Therneau, Terry M. ;

Larson, Dirk ;

Benson, Joanne ;

Clark, Raynell J. ;

Melton, L. Joseph, III ;

Gertz, Morie A. ;

Kumar, Shaji K. ;

Fonseca, Rafael ;

Jelinek, Diane F. ;

Rajkumar, S. Vincent .

BLOOD, 2008, 111 (02) :785-789

[10] International uniform response criteria for multiple myeloma [J].

Durie, B. G. M. ;

Harousseau, J-L ;

Miguel, J. S. ;

Blade, J. ;

Barlogie, B. ;

Anderson, K. ;

Gertz, M. ;

Dimopoulos, M. ;

Westin, J. ;

Sonneveld, P. ;

Ludwig, H. ;

Gahrton, G. ;

Beksac, M. ;

Crowley, J. ;

Belch, A. ;

Boccadaro, M. ;

Turesson, I. ;

Joshua, D. ;

Vesole, D. ;

Kyle, R. ;

Alexanian, R. ;

Tricot, G. ;

Attal, M. ;

Merlini, G. ;

Powles, R. ;

Richardson, P. ;

Shimizu, K. ;

Tosi, P. ;

Morgan, G. ;

Rajkumar, S. V. .

LEUKEMIA, 2006, 20 (09) :1467-1473

← 1 2 3 →